Aimei Health Technology Co., Ltd (NASDAQ:AFJK - Get Free Report) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 1,200 shares, an increase of 20.0% from the November 15th total of 1,000 shares. Based on an average trading volume of 36,500 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company's stock are short sold.
Shares of AFJK opened at $10.62 on Friday. The firm's fifty day simple moving average is $10.57 and its 200-day simple moving average is $10.46. Aimei Health Technology has a twelve month low of $10.15 and a twelve month high of $10.69.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Mizuho Securities USA LLC boosted its position in shares of Aimei Health Technology by 60.7% during the 3rd quarter. Mizuho Securities USA LLC now owns 442,778 shares of the company's stock worth $4,627,000 after acquiring an additional 167,223 shares in the last quarter. Glazer Capital LLC increased its stake in Aimei Health Technology by 7.2% in the second quarter. Glazer Capital LLC now owns 588,774 shares of the company's stock valued at $6,094,000 after purchasing an additional 39,714 shares during the last quarter. Shaolin Capital Management LLC raised its holdings in Aimei Health Technology by 33.3% during the second quarter. Shaolin Capital Management LLC now owns 400,000 shares of the company's stock worth $4,140,000 after purchasing an additional 100,000 shares in the last quarter. Wolverine Asset Management LLC lifted its position in shares of Aimei Health Technology by 8.6% during the 3rd quarter. Wolverine Asset Management LLC now owns 539,039 shares of the company's stock worth $5,649,000 after buying an additional 42,843 shares during the last quarter. Finally, Clear Street LLC acquired a new position in shares of Aimei Health Technology in the 2nd quarter valued at $575,000. 45.58% of the stock is currently owned by institutional investors and hedge funds.
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.